Prospective Cohort of Patient With Coronary Stents Undergoing Non Cardiac Surgery

Multicenter, Prospective Cohort of Patient With Coronary Stents Undergoing Non Cardiac Surgery or Invasive Procedures.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01045850

Acronym

RECO

Enrollment

1312

Registered

2010-01-11

Start date

2006-02-28

Completion date

2010-01-31

Last updated

2010-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Complications, Hemorrhagic Complications

Keywords

coronary stents, non cardiac surgery, cardiovascular complications, hemorrhagic complications, antiplatelet agents, bare metal stent, drug eluting stent, surgery

Brief summary

Non cardiac surgery in patients with coronary stents is complicated with cardiovascular and hemorrhagic events associated with perioperative management of antiplatelet agents. Several guidelines have outlined the importance of maintaining antiplatelet agents throughout surgical procedures to prevent cardiovascular complications. On the other hand, interruption of antiplatelet agents is still a usual standard to avoid surgical complications. We investigate the impact of perioperative antiplatelet drugs management on these complications, through a multicenter, prospective cohort (RECO stands for Registre des patients porteurs d'Endoprothèses Coronaires, Opérés de chirurgie non cardiaque), including all patients with coronary stents undergoing non cardiac surgery or invasive procedures. The aim of this study is primarily to measure the incidence of cardiovascular (including stent thrombosis) and hemorrhagic complications and to identify pre and postoperative risk factors associated with these complications.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years old or more * patient requiring a non cardiac surgery * patient with a coronary stent * patient agree for personal health data collection and analysis

Exclusion criteria

* patient less than 18 years * patient unable to understand

Design outcomes

Primary

Measure	Time frame
Composite cardiovascular and hemorrhagic postoperative complications	30 days

Secondary

Measure	Time frame
Postoperative death	30 days

Countries

France

Outcome results